Business · 15/11/1996Updated: 10/18/2026 · 1 min read
FDA Clears Ibuprofen 200-MG Capsule for Approval
Summary
The US Food and Drug Administration (FDA) has ruled that ibuprofen (Midol) 200-mg capsules were not removed from the market due to safety or efficacy concerns, paving the way for the approval of generic versions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →